• Abiraterone Active in Androgen Receptor-Positive Salivary Tumors

    11 days ago - By MedPageToday

    A majority of patients with previously treated androgen receptor -expressing salivary gland cancer achieved disease control with abiraterone plus a luteinizing hormone-releasing hormone agonist, a small...
    Read more ...